Polymorphisms of oxidation at carbon centers of drugs and their clinical significance.
D003647:Debrisoquin / Q000008:administration & dosage / Q000378:metabolism; D004358:Drug Therapy; D005823:Genetics; D006146:Guanidines / Q000378:metabolism; D006801:Humans; D006900:Hydroxylation; D007700:Kinetics; D010084:Oxidation-Reduction; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010615:Phenacetin / Q000378:metabolism; D010641:Phenotype; D013237:Stereoisomerism
D006146:Guanidines; D004364:Pharmaceutical Preparations; D010615:Phenacetin; D003647:Debrisoquin